Skip to main content

Hee-tae Yoo

Yonsei University · 医学

研究室紹介

Professor Hee-tae Yoo's research lab specializes in cardiovascular medicine with a focus on atrial fibrillation (AF) management, anticoagulation therapy, and the pathophysiological mechanisms underlying stroke and arrhythmia. The lab investigates real-world effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs), particularly edoxaban, in relation to renal function and dosing adherence. It also explores the role of immune senescence, especially cytomegalovirus-driven T-cell aging, in arterial stiffness and cardiovascular risk. Additionally, the lab examines sex differences in left atrial remodeling and outcomes following catheter ablation in AF patients.

atrial fibrillationanticoagulationarterial stiffnessimmune senescencecatheter ablation

Research Overview

Papers
404
Total Citations
6,672
Papers (5y)
204
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
204total
2022
2023
2024
2025
2026
Citations per year (5y)
1,177total
20222023202420252026

Selected Papers

15
1
Article|96 citations·2014
Characterization of CD8+CD57+ T cells in patients with acute myocardial infarction
Hee Tae Yu, Jong‐Chan Youn, Jino Lee, Seunghyun Park, Ho-Seok Chi, Jungsul Lee, Chulhee Choi, Sungha Park, Donghoon Choi, Jong‐Won Ha, Eui‐Cheol Shin
SJR Q1Cellular and Molecular ImmunologyOA
ImmunologyImmunology and Microbiology
2
Article|91 citations·2020
Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
Hee Tae Yu, Pil‐Sung Yang, Eunsun Jang, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Gregory Y.H. Lip, Boyoung Joung
SJR Q1Journal of the American Heart AssociationOA

Background Dose adjustment of non‐vitamin K antagonist oral anticoagulants ( NOAC s) is indicated in some patients with atrial fibrillation ( AF ), based on selected patient factors or concomitant medications. We assessed the frequency of label adherence of NOAC dosing among AF patients and the associations between off‐label NOAC dosing and clinical outcomes. Methods and Results We evaluated 53 649 AF patients treated with an NOAC using Korean National Health Insurance Service database during th

Cardiology and Cardiovascular MedicineMedicine
3
Review|81 citations·2015
T cell senescence and cardiovascular diseases
Hee Tae Yu, Sungha Park, Eui‐Cheol Shin, Won‐Woo Lee
SJR Q1Clinical and Experimental MedicineOA
ImmunologyImmunology and Microbiology
4
Article|68 citations·2017
Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy
Hee Tae Yu, Jaemin Shim, Junbeom Park, In‐Soo Kim, Tae‐Hoon Kim, Jae‐Sun Uhm, Boyoung Joung, Moon‐Hyoung Lee, Young‐Hoon Kim, Hui‐Nam Pak
SJR Q1Circulation Arrhythmia and ElectrophysiologyOA

Background— Atrial fibrillation (AF) type can vary depending on condition and timing, and some patients who initially present with persistent AF may be changed to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether circumferential pulmonary vein isolation (CPVI) alone is an effective rhythm control strategy in patients with persistent AF to paroxysmal AF. Methods and Results— We enrolled 113 patients with persistent AF to paroxysmal AF (male 75%, 60.4±10

Cardiology and Cardiovascular MedicineMedicine
5
Article|50 citations·2017
Arterial Stiffness Is Associated With Cytomegalovirus‐Specific Senescent CD8 + T Cells
Hee Tae Yu, Jong‐Chan Youn, Jong Hoon Kim, Yeon‐Jae Seong, Su‐Hyung Park, Hyeon Chang Kim, Won‐Woo Lee, Sungha Park, Eui‐Cheol Shin, Sungha Park, Eui‐Cheol Shin
SJR Q1Journal of the American Heart AssociationOA

Background Arterial stiffness is a well‐known predictor of future cardiovascular events. Search for the underlying mechanism of arterial stiffening is still under way. We investigated the relationship between arterial stiffness and cytomegalovirus infection in terms of T‐cell senescence. Methods and Results Arterial stiffness was evaluated using pulse wave velocity measurements in 415 Koreans (age 59±12 years). We also investigated the frequency of CD 57 + or CD 28 null senescent T cells in peri

ImmunologyImmunology and Microbiology
6
Article|50 citations·2018
Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation
Hee Tae Yu, Pil‐Sung Yang, Tae‐Hoon Kim, Eunsun Jang, Daehoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Gregory Y.H. Lip, Boyoung Joung
SJR Q1StrokeOA

Background and Purpose- Edoxaban is a direct oral factor Xa inhibitor with proven efficacy and safety among patients with atrial fibrillation. Concerns have been raised about an excess of stroke among patients with creatinine clearance (CrCl) >95 mg/mL treated with edoxaban. We assessed the real-world effectiveness and safety of edoxaban in atrial fibrillation patients in relation to CrCl. Methods- In the Korean National Health Insurance Service data during the period from January to December 20

Cardiology and Cardiovascular MedicineMedicine
7
Article|40 citations·2016
Advanced Left Atrial Remodeling and Appendage Contractile Dysfunction in Women Than in Men Among the Patients With Atrial Fibrillation: Potential Mechanism for Stroke
Hee Tae Yu, Jihei Sara Lee, Tae‐Hoon Kim, Jae‐Sun Uhm, Boyoung Joung, Geu‐Ru Hong, Moon‐Hyoung Lee, Chi Young Shim, Hui‐Nam Pak
SJR Q1Journal of the American Heart AssociationOA

BACKGROUND: The risk of stroke imposed by atrial fibrillation (AF) is significantly greater in women than men; however, the mechanism remains elusive. We hypothesized that left atrial (LA) remodeling and poor contractile function of LA appendage (LAA) would be more predominant in women than men among AF patients. METHODS AND RESULTS: A total of 579 AF patients (216 women vs age-, AF type-, and incidences of heart failure, hypertension, diabetes mellitus, stroke or transient ischemic attack, and

Cardiology and Cardiovascular MedicineMedicine
8
Article|39 citations·2020
Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation
Hee Tae Yu, In‐Soo Kim, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Boyoung Joung, Moon‐Hyoung Lee, Hui‐Nam Pak
SJR Q1Journal of Cardiovascular ElectrophysiologyOA

INSTRUCTION: Longer atrial fibrillation (AF) durations have higher recurrence rates after rhythm control. However, there is limited data on the effect of the AF duration on recurrence after atrial fibrillation catheter ablation (AFCA). In the present study, we investigated the rhythm outcome of AFCA according to the AF duration based on the first electrocardiogram (ECG) diagnosis. METHODS AND RESULTS: We included 1005 patients with AF (75% male, 59 ± 11 years old) who underwent AFCA and whose fi

Cardiology and Cardiovascular MedicineMedicine
9
Article|38 citations·2016
Prognosis of high sinus heart rate after catheter ablation for atrial fibrillation
Hee Tae Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Boyoung Joung, Moon‐Hyoung Lee, Hui‐Nam Pak
SJR Q1EP EuropaceOA

Post-AF ablation high sinus HR was observed in patients with smaller LA size and higher LA electrogram voltage and significant vagal modulation without adverse cardiac effects. Post-AF ablation high sinus HR was associated with a significantly lower clinical recurrence of AF after catheter ablation.

Cardiology and Cardiovascular MedicineMedicine
10
Article|37 citations·2018
Poor Rhythm Outcome of Catheter Ablation for Early-Onset Atrial Fibrillation in Women ― Mechanistic Insight ―
Hee Tae Yu, Pil‐Sung Yang, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Boyoung Joung, Moon‐Hyoung Lee, Hui‐Nam Pak
SJR Q1Circulation JournalOA

Among patients with early-onset AF who underwent catheter ablation, women showed poorer clinical outcomes than men after de novo and second procedures. Left ventricular dysfunction, LA remodeling, and autonomic nervous function may be potential mechanisms underlying sex differences in catheter ablation outcomes of early-onset AF.

Cardiology and Cardiovascular MedicineMedicine
11
Article|37 citations·2018
When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study
Hee Tae Yu, Jaemin Shim, Junbeom Park, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Boyoung Joung, Moon‐Hyoung Lee, Young‐Hoon Kim, Hui‐Nam Pak
SJR Q1European Heart JournalOA

AIMS: Although a recent expert consensus statement has recommended periprocedural uninterrupted (UI) non-vitamin K antagonist oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) as a Class I indication, there have been no clear randomized trials. We investigated the safety and efficacy of UI, procedure day single-dose skipped (SDS), and 24-hour skipped (24S) NOACs in patients undergoing AF ablation. METHODS AND RESULTS: In this prospective, open-label, randomized mul

Cardiology and Cardiovascular MedicineMedicine
12
Article|33 citations·2016
Clinical Significance of Hematuria in Atrial Fibrillation With Oral Anticoagulation Therapy
Hee Tae Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung
SJR Q1Circulation JournalOA

OAT was associated with a higher prevalence and early detection of genitourinary cancer in AF patients with hematuria. Meticulous evaluation of the cause of hematuria is necessary in AF patients with hematuria receiving OAT.

Cardiology and Cardiovascular MedicineMedicine
13
Article|28 citations·2024
Artificial intelligence–derived electrocardiographic aging and risk of atrial fibrillation: a multi-national study
Seunghoon Cho, Sujeong Eom, Daehoon Kim, Tae‐Hoon Kim, Jae‐Sun Uhm, Hui‐Nam Pak, Moon‐Hyoung Lee, Pil‐Sung Yang, Eunjung Lee, Zachi I. Attia, Paul A. Friedman, Seng Chan You
SJR Q1European Heart JournalOA

BACKGROUND AND AIMS: Artificial intelligence (AI) algorithms in 12-lead electrocardiogram (ECG) provides promising age prediction methods. This study investigated whether the discrepancy between ECG-derived AI-predicted age (AI-ECG age) and chronological age, termed electrocardiographic aging (ECG aging), is associated with atrial fibrillation (AF) risk. METHODS: An AI-ECG age prediction model was developed using a large-scale dataset (1 533 042 ECGs from 689 639 participants) and validated with

Cardiology and Cardiovascular MedicineMedicine
14
Article|27 citations·2023
Late recurrence of atrial fibrillation 5 years after catheter ablation: predictors and outcome
Sung Hwa Choi, Hee Tae Yu, Daehoon Kim, Je‐Wook Park, Tae‐Hoon Kim, Jae‐Sun Uhm, Boyoung Joung, Moon‐Hyoung Lee, Chun Hwang, Hui‐Nam Pak
SJR Q1EP EuropaceOA

AIMS: Atrial fibrillation (AF) is a chronic progressive disease that continuously recurs even after successful AF catheter ablation (AFCA). We explored the mechanism of long-term recurrence by comparing patient characteristics and redo-ablation findings. METHODS AND RESULTS: Among the 4248 patients who underwent a de novo AFCA and protocol-based rhythm follow-up at a single centre, we enrolled 1417 patients [71.7% male, aged 60.0 (52.0-67.0) years, 57.9% paroxysmal AF] who experienced clinical r

Cardiology and Cardiovascular MedicineMedicine
15
Article|24 citations·2011
Gender-Based Differences in the Management and Prognosis of Acute Coronary Syndrome in Korea
Hee Tae Yu, Kwang Joon Kim, Woo-Dae Bang, Chang‐Myung Oh, Ji‐Yong Jang, Sung-Soo Cho, Jung‐Sun Kim, Young‐Guk Ko, Donghoon Choi, Myeong‐Ki Hong, Yangsoo Jang
SJR Q2Yonsei Medical JournalOA

PURPOSE: Gender-based differences exist in the characteristics, management, and prognosis of acute coronary syndrome (ACS). However, their impact on prognosis remains unclear. We aimed to identify factors causing these differences in Koreans. MATERIALS AND METHODS: We examined 6,636 ACS patients (66.2% males) visiting 72 Korean hospitals between April-2007 and December-2008. Gender-based differences in clinical demographics, therapy, and outcomes were analyzed over 6 months. RESULTS: Women were

Cardiology and Cardiovascular MedicineMedicine

Research Areas

Cardiology and Cardiovascular MedicineImmunologySurgeryEpidemiologyPhysiologyRadiology, Nuclear Medicine and Imaging

Hee-tae Yooの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。